Suilysin-induced Platelet-Neutrophil Complexes Formation is Triggered by Pore Formation-dependent Calcium Influx

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhang, Shengwei ^a,b   Zheng, Yuling ^a   Chen, Shaolong ^a   Huang, Shujing ^c   Liu, Keke ^a   Lv, Qingyu ^a   Jiang, Yongqiang ^a   Yuan, Yuan ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOLYSIN; PADGEM PROTEIN; SELP PROTEIN, HUMAN; SUILYSIN;

CALCIUM SIGNALING; CELL ADHESION; DRUG EFFECT; HOST PATHOGEN INTERACTION; HUMAN; MICROBIOLOGY; NEUTROPHIL; PHYSIOLOGY; SECRETION (PROCESS); SIGNAL TRANSDUCTION; STREPTOCOCCUS SUIS; THROMBOCYTE;

BLOOD PLATELETS; CALCIUM SIGNALING; CELL ADHESION; HEMOLYSIN PROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; NEUTROPHILS; P-SELECTIN; SIGNAL TRANSDUCTION; STREPTOCOCCUS SUIS;

EID: 84994875607     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep36787     Document Type: Article

References (31)

1. Wertheim, H. F. L., Nghia, H. D. T., Taylor, W. & Schultsz, C. Streptococcus suis: An Emerging Human Pathogen. Clin Infect Dis. 48, 617-625 (2009).
2. Huong, V. T. et al. Epidemiology, clinical manifestations, and outcomes of Streptococcus suis infection in humans. Emerg Infect Dis. 20, 1105-1114 (2014).
3. Sriskandan, S. & Slater, J. D. Invasive disease and toxic shock due to zoonotic Streptococcus suis: an emerging infection in the East? PLoS Med 3, e187 (2006).
4. Tang, J. et al. Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2. Plos Med 3, 668-676 (2006).
5. Yu, H. J. et al. Human Streptococcus suis outbreak, Sichuan, China. Emerg Infect Dis 12, 914-920 (2006).
6. Stahl, A. L. et al. Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood 108, 167-176 (2006).
7. Peters, M. J. et al. Severe meningococcal disease is characterized by early neutrophil but not platelet activation and increased formation and consumption of platelet-neutrophil complexes. J Leukoc Biol 73, 722-730 (2003).
8. Bryant, A. E. et al. Clostridial gas gangrene. II. Phospholipase C-induced activation of platelet gpIIbIIIa mediates vascular occlusion and myonecrosis in Clostridium perfringens gas gangrene. J Infect Dis 182, 808-815 (2000).
9. Bryant, A. E. et al. Vascular dysfunction and ischemic destruction of tissue in Streptococcus pyogenes infection: the role of streptolysin O-induced platelet/neutrophil complexes. J Infect Dis 192, 1014-1022 (2005).
10. Parimon, T. et al. Staphylococcus aureus alpha-hemolysin promotes platelet-neutrophil aggregate formation. J Infect Dis 208, 761-770 (2013).
11. Evangelista, V. et al. Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylationdependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood 93, 876-885 (1999).
12. McEver, R. P. Selectins. Curr Opin Immunol 6, 75-84 (1994).
13. Yang, J., Furie, B. C. & Furie, B. The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyteendothelial and leukocyte-platelet interaction. Thromb Haemost 81, 1-7 (1999).
14. Zarbock, A., Polanowska-Grabowska, R. K. & Ley, K. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev 21, 99-111 (2007).
15. Rebecchi, M. J. & Pentyala, S. N. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol Rev 80, 1291-1335 (2000).
16. Rhee, S. G. Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem 70, 281-312 (2001).
17. Klages, B., Brandt, U., Simon, M. I., Schultz, G. & Offermanns, S. Activation of G12/G13 results in shape change and Rho/Rhokinase- mediated myosin light chain phosphorylation in mouse platelets. J Cell Biol 144, 745-754 (1999).
18. Bird, G. S. et al. Mechanisms of phospholipase C-regulated calcium entry. Curr Mol Med 4, 291-301 (2004).
19. Bennett, J. S. Structure and function of the platelet integrin alphaIIbbeta3. J Clin Invest 115, 3363-3369 (2005).
20. Giddings, K. S., Zhao, J., Sims, P. J. & Tweten, R. K. Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin. Nat Struct Mol Biol 11, 1173-1178 (2004).
21. Xu, L. et al. Crystal structure of cytotoxin protein suilysin from Streptococcus suis. Protein Cell 1, 96-105 (2010).
22. Gottschalk, M. G., Lacouture, S. & Dubreuil, J. D. Characterization of Streptococcus suis capsular type 2 haemolysin. Microbiology 141 (Pt 1), 189-195 (1995).
23. Rossjohn, J., Feil, S. C., McKinstry, W. J., Tweten, R. K. & Parker, M. W. Structure of a cholesterol-binding, thiol-activated cytolysin and a model of its membrane form. Cell 89, 685-692 (1997).
24. Gilbert, R. J. et al. Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae. Cell 97, 647-655 (1999).
25. Ye, C. et al. Clinical, experimental, and genomic differences between intermediately pathogenic, highly pathogenic, and epidemic Streptococcus suis. J Infect Dis 199, 97-107 (2009).
26. Ye, C. et al. Streptococcus suis sequence type 7 outbreak, Sichuan, China. Emerg Infect Dis 12, 1203-1208 (2006).
27. He, Z. et al. Increased production of suilysin contributes to invasive infection of the Streptococcus suis strain 05ZYH33. Mol Med Rep 10, 2819-2826 (2014).
28. Tabata, A. et al. The diversity of receptor recognition in cholesterol-dependent cytolysins. Microbiol Immunol 58, 155-171 (2014).
29. Pian, Y. et al. Fhb, a novel factor H-binding surface protein, contributes to the antiphagocytic ability and virulence of Streptococcus suis. Infect Immun 80, 2402-2413 (2012).
30. Ren, Z. Q. et al. Construction and activities of suilysin mutants. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 28, 580-582 (2012).
31. Shannon, O. et al. Severe streptococcal infection is associated with M protein-induced platelet activation and thrombus formation. Mol Microbiol 65, 1147-1157 (2007).